Sign Up to like & get
recommendations!
1
Published in 2018 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2018.05.008
Abstract: ABSTRACT Human immunodeficiency virus type 1 (HIV‐1)‐induced inflammation and/or long‐term antiretroviral drug toxicity may contribute to the evolution of liver disease. We investigated circulating plasma microRNAs (miRNAs) as potential biomarkers of liver injury in patients…
read more here.
Keywords:
large scale;
hiv mono;
hiv;
mono infections ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "AIDS"
DOI: 10.1097/qad.0000000000002412
Abstract: OBJECTIVE Human immunodeficiency virus (HIV)-infected patients are at increased risk of nonalcoholic steatohepatitis (NASH). Vitamin E is recommended for treatment of NASH in the general population. However, its safety and efficacy among HIV-infected patients remain…
read more here.
Keywords:
hiv mono;
nonalcoholic steatohepatitis;
treatment;
infected patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLOS Computational Biology"
DOI: 10.1371/journal.pcbi.1010744
Abstract: The synergy between human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (MTB) could accelerate the deterioration of immunological functions. Previous studies have explored the pathogenic mechanisms of HIV mono-infection (HMI), MTB mono-infection (MMI) and MTB/HIV co-infection…
read more here.
Keywords:
mtb hiv;
hiv mono;
hiv;
mtb ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Current HIV research"
DOI: 10.2174/1570162x17666190809153245
Abstract: BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is common in HIV-infected individuals. Liver biopsy remains the gold-standard procedure for the diagnosis of liver fibrosis, but both transient elastography(TE) and non-invasive biomarkers(NIBMs) have emerged as alternatives. OBJECTIVES…
read more here.
Keywords:
mono infected;
fibrosis;
hiv mono;
infected patients ... See more keywords